Scientific papers - OPEN Foundation

Ketamine: A Paradigm Shift for Depression Research and Treatment

Krystal, J. H., Abdallah, C. G., Sanacora, G., Charney, D. S., & Duman, R. S. | J. Krystal, C. Abdallah, G. Sanacora, D. Charney, R. Duman | 6 March 2019

Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents

Cameron, L. P., Benson, C. J., DeFelice, B. C., Fiehn, O., & Olson, D. E. | ACS chemical neuroscience | 4 March 2019

5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety

Davis, A. K., So, S., Lancelotta, R., Barsuglia, J. P., & Griffiths, R. R.| The American journal of drug and alcohol abuse | 1 March 2019

Effective connectivity changes in LSD-induced altered states of consciousness in humans

Preller, K. H., Razi, A., Zeidman, P., Stämpfli, P., Friston, K. J., & Vollenweider, F. X. | Proceedings of the National Academy of Sciences | 12 February 2019

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.

Madsen, M. K., Fisher, P. M., Burmester, D., Dyssegaard, A., Stenbæk, D. S., Kristiansen, S., ... & Erritzoe, D. | Neuropsychopharmacology | 26 January 2019

Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants.

Reed, J. L., Nugent, A. C., Furey, M. L., Szczepanik, J. E., Evans, J. W., & Zarate Jr, C. A. | Biological Psychiatry: Cognitive Neuroscience and Neuroimaging | 25 January 2019

Neurochemical models of near-death experiences: A large-scalestudy based on the semantic similarity of written reports

Martial, C., Cassol, H., Charland-Verville, V., Pallavicini, C., Sanz, C., Zamberlan, F., & Tagliazucchi, E. | Consciousness and cognition | 20 January 2019

Transformative Psychopharmacology: the Case of 5-Methoxy-N,N-Dimethyltryptamine

Jan M Keppel Hesselink | International Journal of Psychotherapy Practice and Research | 2 January 2019

Microdosing psychedelics: personality, mental health, and creativity differences in microdosers

Anderson, T., Petranker, R., Rosenbaum, D., Weissman, C. R., Dinh-Williams, L. A., Hui, K., & Farb, N. A. | Psychopharmacology | 2 January 2019

How do psychedelics work?

Carhart-Harris, R. L. | Current opinion in psychiatry | 1 January 2019

Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment‐resistant depression

Salloum, N. C., Fava, M., Freeman, M. P., Flynn, M., Hoeppner, B., Hock, R. S., & Mathew, S. J. | Depression and anxiety | 30 December 2018

Role of serotonin transporter and receptor gene variations in the acute effects of MDMA in healthy subjects

Vizeli, P., Meyer zu Schwabedissen, H. E., & Liechti, M. E. | ACS chemical neuroscience | 27 December 2018

DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens

Lakstygal, A., Kolesnikova, T., Khatsko, S., Zabegalov, K., Volgin, A., Demin, K., & Kalueff, A. | ACS chemical neuroscience | 19 December 2018

Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter

Kuypers, K. P., de la Torre, R., Farré, M., Xicota, L., Perna, E. D. S. F., Theunissen, E. L., & Ramaekers, J. G. | Scientific reports | 18 December 2018

A Jamesian Response to Reductionism in the Neuropsychology of Religious Experience

Kime, K. G., & Snarey, J. R. | Archive for the Psychology of Religion | 13 December 2018

Methylenedioxymethamphetamine (MDMA) in Psychiatry: Pros, Cons, and Suggestions.

Schenk, S., & Newcombe, D. | Journal of clinical psychopharmacology | 12 December 2018

3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats

Hake, H. S., Davis, J. K., Wood, R. R., Tanner, M. K., Loetz, E. C., Sanchez, A., ... & Greenwood, B. N. | Physiology & behavior | 4 December 2018

Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics

Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. | Pharmacology & therapeutics | 4 December 2018

Monoamine biosynthesis via a noncanonical calcium-activatable aromatic amino acid decarboxylase in psilocybin mushroom

Torrens-Spence, M. P., Liu, C. T., Pluskal, T., Chung, Y. K., & Weng, J. K. | ACS chemical biology | 28 November 2018

Self-Experiments with Psychoactive Substances: A Historical Perspective

Passie, T., & Brandt, S. D. | Handbook of Experimental Pharmacology | 27 November 2018

The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial.

Yanakieva, S., Polychroni, N., Family, N., Williams, L. T., Luke, D. P., & Terhune, D. B. | Psychopharmacology | 26 November 2018

An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders

Renelli, M., Fletcher, J., Tupper, K. W., Files, N., Loizaga-Velder, A., & Lafrance, A. | Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity | 24 November 2018